These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 413795)

  • 1. Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
    Heymès R; Lutz A; Schrinner E
    Infection; 1977; 5(4):259-60. PubMed ID: 413795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
    Chantot JF; Bryskier A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):482-6. PubMed ID: 3937124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
    Katsu K; Kitoh K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Aug; 22(2):181-5. PubMed ID: 6100421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
    Arai S; Kobayashi S; Hayashi S
    Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
    Hiruma R; Otsuki M; Tashima M; Obana Y; Nishino T
    J Antimicrob Chemother; 1990 Dec; 26(6):769-81. PubMed ID: 2127928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of HR 756, a new cephalosporin compound.
    Shah PM; Troche G; Stille W
    J Antibiot (Tokyo); 1978 Nov; 31(11):1170-4. PubMed ID: 102631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies concerning the antibacterial spectrum of cephalexin monohydrate].
    Foz A
    Prensa Med Mex; 1970; ():1-15. PubMed ID: 4996100
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT
    Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
    Bassetti M; Righi E
    Future Microbiol; 2015; 10(2):151-60. PubMed ID: 25689527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
    Matsuzaki M; Tado N; Hirata Y; Kato M; Nakumura K
    Jpn J Antibiot; 1976 Jan; 29(1):61-8. PubMed ID: 4635
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
    Hoyme U; Madsen PO
    J Infect Dis; 1978 May; 137 Suppl():S100-S102. PubMed ID: 349091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model.
    Bhalodi AA; Crandon JL; Williams G; Nicolau DP
    Int J Antimicrob Agents; 2014 Dec; 44(6):508-13. PubMed ID: 25278330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new cephalosporin antibiotic, cephapirin.
    Wiesner P; MacGregor R; Bear D; Berman S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1972 Apr; 1(4):303-9. PubMed ID: 4208896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.